Clinicopathological significance of cutaneous epidermal nuclear staining by direct immunofluorescence

Journal of Cutaneous Pathology

Volumn 20, Issue 2, 1993, Pages 159-162

  Burrows, N P ^a   Bhogal, B S ^a   Jones, R Russell ^a   Black, M M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CONTAMINATION; DERMATOMYOSITIS; EPIDERMIS CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOPATHOLOGY; MALE; MIXED CONNECTIVE TISSUE DISEASE; PATHOLOGY; PRIORITY JOURNAL; SARCOIDOSIS; SEROLOGY; SKIN BIOPSY; SKIN LUPUS ERYTHEMATOSUS; SKIN TEST; SYNDROME CREST; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; CONNECTIVE TISSUE DISEASES; EPIDERMIS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; MALE; MIDDLE AGE;

EID: 0027301586     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1993.tb00234.x     Document Type: Article

References (25)

1. The clinical significance of the in vivo antinuclear antibody phenomenon
2. In vivo antinuclear antibody of the skin: diagnostic significance and association with selective antinuclear antibodies
3. Immunofluorescence studies in progressive systemic sclerosis (scleroderma) and mixed connective tissue disease
4. The TH. In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum 17. ANA
5. Mixed connective tissue disease syndrome
6. In vivo nuclear localization of 18 immunoglobulins in clinically normal skin in systemic and procainamide induced lupus erythematosus
7. Epidermal nucleolar IgG deposition in clinically normal skin
8. Mixed connective tissue disease characterized by speckled epidermal nuclear IgG deposition in normal skin
9. Speckled (paniculate) epidermal nuclear IgG deposition in normal skin
10. Oral manifestations in discoid and systemic lupus erythematosus I. Clinical investigation
11. Stratified 22 epithelium specific antinuclear antibodies (SES‐ANA) in chronic ulcerative stomatitis (CUS): Is SES‐ANA associated CLIS a new clinical entity
12. Chronic ulcerative stomatitis associated with a specific immunological marker
13. Ten cases of chronic ulcerative stomatitis with stratified epithelium‐specific antinuclear antibody
14. Patients with erosive lichen planus may have antibodies directed to a nuclear antigen of epithelial cells. A study on the antigen nature
15. The speckled immunofluorescence of epidermal nuclei as an in vivo phenomenon
16. The significance of cutaneous immunoglobulin deposits in lupus erythematosus and NZB/NZW hybrid mice
17. The speckled epidermal nuclear immunofluorescence of mixed connective tissue disease seems to develop as an in vitro phenomenon
18. In vivo intracellular deposition of antinuclear antibodies in Henoch‐Schonlein purpura. (Letter)
19. Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes
20. Binding of antibodies lo the extractable nuclear antigens SSA/Ro and SSB/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus
21. Binding of antibodies to nonhistone nucleoproteins on keratinocytes in suspensions
22. Pathogenesis of in vivo antinuclear antibodies of the skin. (Letter)
23. Nuclear deposits of immunoglobulin in skin of patients with systemic lupus erythematosus
24. In vitro complement activation by antinuclear antibodies in the epidermis from patients with systemic sclerosis
25. In vitro study of the binding of antiribonucleoprotein antibodies to the nuclues of isolated living keratinocytes